Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 to be a ...

I pray that she carries the love that she felt tonight every day that she has," said friend Rita Monteiro, who organized the ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Astrocytes, critical brain cells, are often lost in neurodegenerative diseases, but recent research highlights the promise of ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...